User profiles for R.T. Groeschl

Ryan Groeschl

Mayo Clinic
Verified email at mayo.edu
Cited by 2916

[HTML][HTML] Systematic review of outcomes of patients undergoing resection for colorectal liver metastases in the setting of extra hepatic disease

…, DE Green, B George, JP Thomas, RT Groeschl… - European journal of …, 2014 - Elsevier
Background Surgical resection for patients with colorectal liver metastases (CRLM) can offer
patients a significant survival benefit. We hypothesised that patients with CRLM and extra …

[HTML][HTML] Modern perspectives on factors predisposing to the development of gallbladder cancer

CHC Pilgrim, RT Groeschl, KK Christians, TC Gamblin - Hpb, 2013 - Elsevier
… imaging using computed tomography or magnetic resonance imaging, in addition to
ultrasound, and with the subsequent exclusion of T-stage II or III GBC, the laparoscopic route also …

Microwave ablation for hepatic malignancies: a multiinstitutional analysis

RT Groeschl, CHC Pilgrim, EM Hanna, KA Simo… - Annals of …, 2014 - journals.lww.com
Objective: This study hypothesized that tumor size, number of tumors, surgical approach, and
tumor histology significantly affected microwave ablation (MWA) success and recurrence-…

Carbohydrate antigen 19-9 elevation in anatomically resectable, early stage pancreatic cancer is independently associated with decreased overall survival and an …

…, CA Puig, CR Shubert, RT Groeschl… - Journal of the American …, 2016 - Elsevier
Background Patient triage in anatomically resectable, early stage pancreatic ductal
adenocarcinoma (PDAC) with elevated carbohydrate antigen 19-9 (CA 19-9) remains unclear. We …

Hepatectomy for noncolorectal non-neuroendocrine metastatic cancer: a multi-institutional analysis

RT Groeschl, I Nachmany, JL Steel, SK Reddy… - Journal of the American …, 2012 - Elsevier
BACKGROUND: Although hepatic metastasectomy is well established for colorectal and
neuroendocrine cancer, the approach to hepatic metastases from other sites is not well defined. …

Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targets

…, A Ejaz, S Alexandrescu, RT Groeschl… - Annals of surgical …, 2014 - Springer
Background The molecular alterations that drive tumorigenesis in intrahepatic cholangiocarcinoma
(ICC) remain poorly defined. We sought to determine the incidence and prognostic …

Indications and perioperative outcomes for pancreatectomy with arterial resection

MC Tee, AC Krajewski, RT Groeschl, MB Farnell… - Journal of the American …, 2018 - Elsevier
Background Pancreatectomy with arterial resection (AR) is performed infrequently. As indications
evolve, we evaluated indications, outcomes, and predictors of mortality, morbidity, and …

Microwave ablation for hepatic malignancies: a call for standard reporting and outcomes

DA North, RT Groeschl, D Sindram, JB Martinie… - The American Journal of …, 2014 - Elsevier
Background Clinical standards of reporting microwave ablation outcomes have not been
defined with regard to ablation success, 90-day morbidity, local recurrence after ablation, and …

Transplantation versus resection for patients with combined hepatocellular carcinoma–cholangiocarcinoma

RT Groeschl, KK Turaga… - Journal of surgical …, 2013 - Wiley Online Library
Background and Objectives Although transplantation has demonstrated survival benefit for
patients with hepatocellular carcinoma (HCC), there is limited data to support or refute …

Overall survival is increased among stage III pancreatic adenocarcinoma patients receiving neoadjuvant chemotherapy compared to surgery first and adjuvant …

CR Shubert, JR Bergquist, RT Groeschl… - Surgery, 2016 - Elsevier
Background Outcomes of neoadjuvant systemic therapy versus an upfront operation for
clinical, stage III pancreatic adenocarcinoma remain poorly defined. Our aim was to compare …